US states, Caribbean nations back Mexico's appeal in arms lawsuit
The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH).March 22 (Reuters) - Regeneron Pharmaceuticals Inc said on Wednesday the U.S.Food and Drug Adminis...
